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Necrotizing enterocolitis (NEC) is a severe neonatal disease aﬀecting particularly preterm infants. Its exact pathogenesis still
remains unknown. In this study, we have compared the prevalence of vascular obstructive lesions in placentae of premature
newborns which developed NEC and of a control group. We further compared separately the findings of placentae of infants
of less than 30 weeks of gestation, the age group in which NEC occurs most frequently. We found signs of fetal vascular obstructive
lesions in 65% of the placentae of preterm patients developing NEC, compared to only 17% of the placentae of preterm patients
in the control group. In the age groups below 30 weeks of gestation, 58.5% of placentae of later NEC patients presented such
lesions compared to 24.5% in the control group. The significant diﬀerence between NEC and control group suggests a strong
association between fetal vascular obstructive lesions and NEC. Therefore, we propose that fetal vascular obstructive lesions might
be considered as a risk factor for the development of NEC in premature infants.
1. Introduction
Necrotizing enterocolitis (NEC) is one of the most dreadful
and unpredictable emergencies in premature infants [1,
2]. Its incidence is around 7% in very low-birth-weight
infants (VLBW, birth weight <1500 g) [1, 3] and almost
absent in full-term neonates [4]. The exact pathogenesis
of NEC is still unknown. Many etiologic conditions have
been described favorizing the development of NEC, such
as gut immaturity, decreased gut motility, gastrointestinal
bacterial colonization, and accelerated feeding [5–7]. Dif-
ferent authors suggested intestinal ischemia and hypoxia as
important risk factors. The earlier proposed “diving reflex”
in neonates suﬀering from severe hypoxic episodes with
diversion of blood preferentially to heart, brain, and kidneys
resulting in decreased perfusion of the intestinal tract could
not explain all facets of the pathophysiology of NEC [8].
However, some pieces of evidence support the idea that
hypoxic-ischemic events may play an important role in its
etiology. (1) The ileocecal region which is often involved in
NEC corresponds to an intestinal “watershed” area which
might explain its susceptibility to hypoxic-ischemic events.
(2) Reduced perfusion plays an important role in the
pathophysiology of coagulation necrosis which represents
one of the major histological findings of NEC [9]. (3) The
rare condition of NEC in term infants is often associated with
reduced intestinal perfusion secondary to congenital heart
disease, patent ductus arteriosus, hypoxic-ischemic events, or
polycythemia [10–12]. (4) Preterm infants showing a high-
resistance flow pattern in the superior mesenteric artery on
the first day of life were shown to be at higher risk to develop
NEC later in their postnatal course [13]. These findings
suggest that NEC might be associated with a disorder in
regulation of splanchnic circulation in postnatal life. It has
been shown in preterm infants developing NEC that their
arginine level, a substrate for the synthesis of the import
vasodilator nitric oxide, was reduced not only at the time of
diagnosis [14] but already a week before the development
of NEC [15]. Other situations which increase vascular
resistance in the mesenteric arteries might be abnormalities
of the development of the splanchnic circulation. Therefore,
we hypothesized that a reduced mesenteric perfusion present
already during fetal life might impede normal splanchnic
vascular and gut development and create an increased
vulnerability of the intestine. The most important causes of
reduced fetal perfusion are maternofetal blood circulation
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disorders [16–19]. Chronic hypoxic-ischemic lesions due
to placental insuﬃciency have been described to be most
often the consequence of obstructive vascular lesions in the
placenta, known as fetal vascular obstructive lesions [20].
We hypothesized that vascular obstructive lesions, rep-
resenting a marker of maternofetal circulation disorders,
might be overrepresented in placentae of neonates who will
develop NEC in their postnatal course. In order to test
this hypothesis, we have determined the prevalence of fetal
vascular obstructive lesions in placentae of newborn infants
who developed NEC and compared these findings with those
of placentae of a control group.
2. Material and Methods
2.1. Patients and Study Groups. The discharge letters of
all patients, hospitalized in the Division of Neonatology
of the University Hospital of Lausanne, Switzerland, over
an eleven-year period starting January 1994 were analyzed
retrospectively with regard to the diagnosis of NEC. The
Division of Neonatology in Lausanne is the only tertiary
reference center for a region with about 12–14 000 births
per year and accounts for about 500 annual admissions.
Among all hospitalized patients, we identified 89 infants
suﬀering from NEC (Bell stage II and more) [21, 22]. For
these patients the archive of the Institute of Pathology of the
University of Lausanne was screened. In 77 of the 89 cases
(86.5%) the placenta had been sent to our institute and was
available for reexamination. The placentae from the patients
with NEC were considered the study group. As control group
we could not use the total of placentae received during the
same period because of technical problems due to a software
change. Our institution received over the study period
between 750 and 800 placentae per year. Considering that
during eleven years only 89 patients with NECwere recorded,
representing about 8 patients per year, the study group
corresponded to about 1% of all the placentae received for
analysis. According to these data, we have defined as control
group the 769 placentae consecutively sent to our institution
for histological examination during a one-year period (April
2006 to March 2007), an accepted methodology in the
literature [23]. Indications for histological examination of
the placenta in our area are maternal health problems like
arterial hypertension, diabetes, hemorrhage or evidence of
infection, intrauterine disorders like stillbirth or abnormal
intrauterine growth as well as postnatal adaptation prob-
lems, prematurity, multiple births, and delivery by cesarean
section. Placentae from completely normal pregnancies at
term are usually not submitted for histological examination.
Clinical information is provided by the demanding obstetri-
cian or pediatrician on a clinical data form which includes
information related to present and previous pregnancies,
maternal diseases, clinical observations of the amniotic fluid,
appearance of the placenta at delivery, information about
the newborn as well as the indication for the examination.
Due to the fact that NEC is mainly occurring in preterm
infants (gestational age (GA) <37 weeks) and particularly
in very preterm infants (GA <30 weeks), we did subsequent
subgroup analysis taking into account only preterm and
very premature infants labeled as preterm control group
(<37weeks) and very preterm control group (<30weeks).
2.2. Placental Examination. All placentae were examined
following a standard procedure as recently described [24].
In brief, all placentae were fixed for 48 hours in formalin
in order to minimize artifacts due to diﬀerent time lapses
of fixation. Macroscopic findings such as abnormalities
of structure, membranes (mother and fetal side), and
umbilical cord were obtained and described. Placental weight
was recorded after removing the umbilical cord and the
amniotic membranes. Thereafter, the placentae were sliced
every centimeter and lesions, if macroscopically evident,
described and measured. Six to eight specimens were taken
for microscopic examination from each placenta, including
cord sections, and roll of membranes, cord insertion region,
and at least three specimens from the placental parenchyma.
The paraﬃn-embedded tissue blocks were then cut to a
thickness of five microns, and routine histological staining
was performed using hematoxylin and eosin. For study
purposes, all placentae were reexamined independently by
two diﬀerent pathologists (LD and MCO).
2.3. Histological Definitions. Special interest was laid on the
presence of fetal obstructive vascular lesions according to
Baergen [25]. The presence of at least one of the diﬀerent
manifestations of obstructive lesions was defined as fetal
vascular obstructive lesions. The lesions were documented
for each specimen according to the following definition
(Figure 1). Thrombosis (IT and MT): presence of an isolated
mural thrombus (IT) or multiple obstructive thrombi (MT)
with or without complete obliteration of the vessel. Usually
the veins are more frequently aﬀected than the arteries.
Prolonged occlusion by a thrombus mainly in the arterial
circulation induces that the villous tree becomes avascular
and atrophic. Therefore, we considered an avascular villi as
direct evidence of thrombosis even without the possibility to
localize a frank thrombus within the vessel. Avascular villi
characterized by hyaline quality of the villous stroma were
counted as IT for single ones or MT for multiple occur-
rence. Obliterative endarteritis (OE): distal vessels presenting
fibrotic thickening of the vascular walls (also called fibromus-
cular sclerosis), with or without obliteration of the lumen.
Hemorrhagic endovasculitis (HEV): microscopic criteria for
the diagnosis of HEV include disruption or nonexudative
necrosis of the vessel wall with hemorrhage, erythrocyte
fragmentation, and intravascular nucleoplasmatic debris.
HEV has been described in placentae from live newborns and
stillborn fetuses and seems to be associated with an increase
in perinatal complications [24].
2.4. Statistics. The study hypothesis was that the presence of
placental vascular lesions might be significantly associated
with the occurrence of NEC. Fischer’s exact test was used to
analyze correlations between the study and control groups.
P < .05 was considered statistically significant.
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Figure 1: Characteristic histological findings of placental vascular obstructive lesions (all images colored by hematoxylin and eosin;
magnification 40×). (a) Occlusive thrombus (arrow) in a dilated chorionic vein. (b) Hemorrhagic endovasculitis (HEV): extravasated blood
cells (arrow) around a vessel in a stem villus. (c) Muscular hypertrophy and old occlusions (arrows) in stem vessels (obliterative endarteritis)
(OE). (d) Avascular villi demonstrating hyaline villous stroma devoid of vessels.
2.5. Ethical Considerations. All patient data and pathological
material were selected and handled according to the rules of
the University Hospital of Lausanne, Switzerland.
3. Results
During the 11-year study period, 89 patients have been
diagnosed with NEC (Bell stage II or higher). The study
group consisted of 77 placentae which were available for
reexamination. GA ranged between 23 6/7 and 36 2/7 weeks
(mean: 28 4/7 weeks, median: 29 3/7 weeks). The average
birth weight of the study group patients was 1520 g (range
950–2400 g) for those of GA between 30 and 37 weeks and
852 g (range 440–1840 g) for the NEC patients with GA
< 30 weeks. The average birth weight of the investigated
term neonates of the control group was 2669 g (range 1630–
4250 g), 2187 g (range 1300–3140 g) for the preterm control
infants between 30 and 37 weeks of gestation, and 693 g
(range 306–1050 g) for the very preterm controls with GA
< 30 weeks.
The average weight of the placenta in the study group was
343 g (range 140–650 g) for the preterm pregnancies between
30 and 37 weeks and 206 g (range 90–221 g) for the very
preterm pregnancies. The average placental weight of the
769 placentae in the control groups was similar: 421 g (range
242–935 g) for the term infants, 357 g (range 135–985 g) for
the pregnancies between 30 and 37 weeks of GA, and 231 g
(range 172–496 g) for the very preterm pregnancies (GA <
30weeks).
Macroscopically, the umbilical cord insertion was found
in a comparable relative distribution in all the diﬀerent
groups: eccentric insertion in 50% of the study preterm
group and 52.5% in the study very preterm group and in
the controls: 57.5% in term placentae, 51.5% in preterm,
and 49.2% in very preterm control placentae. Marginal
insertion was described in 18.5% of the study preterm
group, 25% of study very preterm group and in 17.4% in
term controls, in 21.5% of preterm controls, and 19.4%
of very preterm controls. Central insertion was found in
a percentage between 12.5% and 23.9% in all groups and
velamentous insertion was observed in a range of 4% to
13%. Interpositional insertion was only observed in 1% of
the term control placentae. In the 77-later NEC patients only
5 cases (6.5%) of a false knot but no true knot were found.
In the control group one true and 72 false knots (9.4%) were
described.
In one or more samples of 50 of the 77 placentae
(64.9%) of the study group we found at least one of the
four histological alterations of obstructive vascular lesions
(Table 1). A total of 141 obstructive vascular lesions was
observed in 130 of the analyzed 769 control placentae
leading to a significantly lower prevalence of 16.9% in the
control group. In the preterm subgroup, placentae of control
newborns showedwith 16.8% (47 of 279 cases) a significantly
lower percentage of vascular obstructive lesions compared to
the preterm study group (64.9%; 50/77).
Overall, we observed 71 lesions in the 50 pathological
placentae of the study group. The most frequent obser-
vation was multiple thrombi (MT) which were present
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Table 1: FVOL: fetal vascular obstructive lesions defined as placentae with the presence of one or more of the following lesions: MT:
multiple thrombi, IT: isolated thrombus, OE: obliterative endarteritis, HEV: hemorrhagic endovasculitis. P-value∗: comparison between the
three diﬀerent control groups and the study group∗ P-value∗∗: comparison between the very preterm control group and the very preterm
study group∗∗.
Total number of
placentae
FVOL
Type of vascular obstructive lesions
MT IT OE HEV
Study group∗ 77 50 (64.9%) 30 (39.0%) 15 (19.5%) 15 (19.5%) 11 (14.3%)
Very preterm study group
(<30 weeks)∗∗
41 24 (58.5%) 14 (34.1%) 10 (24.4%) 5 (12.2%) 3 (7.3%)
Control group
P-value∗
769
130 (16.9%)
.0001∗
37 (4.8%)
.0001∗
59 (7.7%)
.0021∗
20 (2.6%)
.0001∗
25 (3.3%)
.0002∗
Preterm control group (<37 weeks)
P-value∗ 279
47 (16.8%)
.0001∗
15 (5.4%)
.0001∗
27 (9.7%)
.00268∗
9 (3.2%)
.0001∗
7 (2.5%)
.0002∗
Very preterm control group
(<30 weeks)
P-value∗
P-value∗∗
53
13 (24.5%)
.0001∗
.0013∗∗
7 (13.2%)
.0015∗
.0237∗∗
5 (9.4%)
.1427∗
.086∗∗
4 (7.5%)
.0772∗
.049∗∗
3 (5.7%)
.1547∗
1.000∗∗
in 30 (39.0%) of all placentae (Table 1). In the corresponding
preterm control group, MT were rarer observations with
a presence of only 5.4% (15/279 cases). All these results
were statistically highly significantly diﬀerent from those
of the study group (P < .0001) (Table 1). The rest of the
lesions like IT, OE, and HEV were also found more
frequently in the study group compared to preterm control
placentae.
The comparison of the subgroup of patients with the
highest risk to develop NEC, the very preterm infants
(<30weeks), confirmed the above-mentioned diﬀerences.
In the very preterm study group we diagnosed fetal vas-
cular obstructive lesions in 24 of the 41 placentae corre-
sponding to a prevalence of 58.5%. In the very preterm
control group only 13 of 53 placentae showed one or
more of these pathologies, representing a significantly lower
prevalence of fetal vascular obstructive lesions with only
24.5% (P < .0001; Table 1). The pattern of lesions showed
also a trend to more important pathologies in later-NEC
patients, represented by a significantly higher number of MT
lesions in the very preterm study group (34.1%) compared
to the age-matched controls (7/53 (13.2%), P = .023)
(Table 1).
Chorioamnionitis and vasculitis may favor the forma-
tion of chorionic vessel thrombi. In order to omit this
potentially confounding factor we analyzed the placentae
with fetal vascular obstructive lesions regarding the presence
of chorioamnionitis and/or vasculitis (Table 2). Although
there was a high number of cases combining vascular
obstructive lesions with chorioamnionitis and/or vasculi-
tis, the above mentioned significant diﬀerences persisted
with a higher prevalence of vascular obstructive lesions
without chorioamnionitis and vasculitis in the placen-
tae of future NEC patients compared to the controls
(Table 2).
4. Discussion
NEC is a severe neonatal disease with a high degree of
morbidity and an important mortality complicating the
postnatal course of mainly premature newborn infants [1,
5, 26]. Although many etiologies proposed in the literature,
the exact pathophysiological mechanism of NEC is still
unclear. A multifactorial origin is very likely. Prematurity
and low gestational age seem to be the most consistent
risk factors [2, 3, 27]. Genetic predisposition and ethnic
diﬀerences as well as altered or immature intestinal defense
mechanisms and nutritional factors have been incriminated
[5, 27]. Diﬀerent studies suggested an implication of per-
fusion disturbances in the etiology of NEC like persistence
and treatment modalities of ductus arteriosus or other
pathological flow patterns in mesenteric arteries [2, 13]. The
idea that placental insuﬃciency with a reduced perfusion
pattern already in fetal life might have an impact on the
occurrence of NEC was the topic of several studies and
of a recent meta-analysis [28]. In fact, there seems to be
an association between disturbed fetal perfusion patterns
and the incidence of NEC [28, 29]. Although it is diﬃcult
to demonstrate a clear predictive value of pathologic fetal
doppler measurements and the postnatal development of
NEC, it might be reasonable to assume that a hypoxic-
ischemic perfusion status of the fetus could contribute to
some degree of vulnerability of the intestine leading to a
predisposition to develop NEC later in postnatal life [28,
30].
Fetal vascular obstructive lesions are the result of stasis,
hypercoagulability, and vascular damage within the fetal
circulation of the placenta. They have been associated
with fetal growth restriction and chronic fetal monitoring
abnormalities. Placental lesions associated with fetal vascular
obstruction have long been recognized and described using
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Table 2: Prevalence of chorioamnionitis (CA) and vasculitis in the diﬀerent study populations. Comparisons are given between vascular
obstructive lesions associated with chorioamnionitis, vasculitis, and without these inflammatory conditions. P-value∗: comparison between
the three diﬀerent control groups and the corresponding study group. P-value∗∗: comparison between the very preterm control group and
the very preterm study group∗∗.
Number of
placentae with CA
Number of
placentae
with vasculitis
Vascular obstructive lesions
With CA With vasculitis
Without CA and
vasculitis
Study group∗ 16 (20.8%) 14 (18.2%) 12 (15.6%) 9 (11.7%) 37 (48%)
Very preterm study group
(<30 weeks)∗∗ 12 (29.2%) 9 (21.9%) 7 (17%) 5 (12.2%) 19 (46.3%)
Control group (<37 weeks)
P-value∗
138 (17.9%) 101 (13.1%)
16 (2.1%)
.0001∗
5 (0.65%)
.0001∗
93 (12.25%)
.0001∗
Preterm control group (<37 weeks)
P-value∗
29 (10.4%) 34 (12.2%)
1 (0.36%)
.0001∗
1 (0.36%)
.0001∗
39 (14%)
.0001∗
Very preterm control group
(<30 weeks)
P-value∗
P-value∗∗
32 (60%) 26 (49%)
5 (9.4%)
.4373∗
.5420∗∗
1 (1.9%)
.0885∗
.0999∗∗
7 (13.2%)
.0031∗
.0150∗∗
a variety of diﬀerent names. Gruenwald was the first in
1961 to describe the clinical significance of avascular villi
and their relationship to fetal thrombosis [31]. Others
reported a high prevalence of disruptive fetal vascular
lesions in term infants with adverse outcome and used
the term of “hemorrhagic endovasculitis” to describe the
spectrum of resulting placental changes [32–34]. Redline
and Pappin highlighted the importance of even small foci
of avascular villi in the absence of vascular thrombi and
proposed the term of “fetal thrombotic vasculopathy” (FTV)
[35]. This kind of placental lesions has been implicated in
pathologies like cerebral palsy, fetal thromboembolic disease,
intrauterine growth restriction, intrapartum monitoring
abnormalities and discordant growth in twin pregnancies
[19, 23, 36–41]. Severe fetal vascular lesions have been
observed in over 50% of patients with hypoxic-ischemic
encephalopathy or cerebral palsy at term [37]. Ogunyemi et
al. have found among other pathologies a fourfold higher
association of placental vascular abnormalities and NEC
[42]. However, to our knowledge, any study so far has
specifically evaluated the relationship between fetal vascular
obstructive lesions and NEC. In this study we have compared
the prevalence and the importance of obstructive vascular
lesions in placentae of premature newborns which developed
NEC and of a control group. We found a highly significant
increase of fetal vascular obstructive lesions in placentae
of newborns with NEC compared to the placentae of
the control group. Previous studies have related placental
pathology to preeclampsia, stillbirth, IUGR, and preterm
labor suggesting that fetal vascular obstructive lesions might
be responsible for prematurity but not directly for NEC
[7, 22, 41–43]. Nevertheless, our results demonstrate a
significant diﬀerence in prevalence and importance of fetal
vascular obstructive lesions in placentae also among very
preterm patients (<30 weeks of gestation). Those who
developed NEC later in postnatal life had a significantly
higher prevalence of fetal vascular obstructive lesions com-
pared to age-matched control counterparts. These significant
diﬀerences persisted also after correction for the presence
of chorioamnionitis or vasculitis. Due to these findings
of consistent association between fetal vascular obstructive
lesions and NEC, in particular the presence of MT in the
fetal placental vascular bed, we suggest that fetal vascular
obstructive lesions have to be considered as an additional
risk factor for NEC. As the result of the histopathological
examination is available early in the postnatal course of a
newborn infant, this information might alert the neonatol-
ogists in order to consider preventive or early therapeutic
strategies.
In conclusion, we found an almost fourfold higher
prevalence of fetal vascular obstructive lesions in placentae
of future NEC patients compared to controls. We therefore
strongly advocate a careful examination of placentae from
premature babies in order to reveal the presence of fetal
vascular lesions and, if present, to inform the neonatologists
of the increased risk for the development of NEC.
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